Apr 3
|
Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street
|
Apr 2
|
3 Dividend Stocks To Consider With Yields Up To 4.2%
|
Apr 2
|
Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It?
|
Apr 2
|
The Zacks Analyst Blog Highlights Amazon.com, Oracle and Merck
|
Apr 1
|
Top Analyst Reports for Amazon, Oracle & Merck
|
Apr 1
|
Merck to Hold First-Quarter 2025 Sales and Earnings Conference Call April 24
|
Mar 31
|
Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?
|
Mar 31
|
Merck (NYSE:MRK) Reports Strong Phase 3 Results For WINREVAIR In PAH Treatment
|
Mar 31
|
WINREVAIR™ (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the Phase 3 ZENITH Trial
|
Feb 24
|
5 Stocks in the Dow ETF That Survived the Worst Week Since October
|
Feb 24
|
Merck to Participate in the TD Cowen 45th Annual Health Care Conference
|
Feb 23
|
Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
|
Feb 22
|
Merck & Co., Inc. (MRK): Among the Most Expensive Stocks Insiders Are Buying Recently
|
Feb 21
|
2 Healthcare Stocks with Big Upside and 1 to Skip
|
Feb 18
|
Merck & Co., Inc. (MRK): Among the Cheap High Dividend Stocks to Invest In Now
|
Feb 18
|
Is Merck & Co., Inc. (MRK) the Best Very Cheap Stock To Buy Right Now?
|
Feb 18
|
Europe Approves Merck's Cancer Drug For Two Indications
|
Feb 18
|
Merck & Co., Inc. (MRK): Among the Best Drug Stocks to Buy Now
|
Feb 18
|
WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications
|
Feb 17
|
Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?
|